Starling Fluid Management Monitoring System

The Starling system is available in select countries globally, including the United States.


Using patented Bioreactance technology, the Starling Fluid Management Monitoring System represents the latest advancements in hemodynamic monitoring, providing easy-to-use, non-invasive technology that delivers accurate and precise data that takes the guesswork out of fluid assessment. The Starling system advances efforts to shift treatment away from a one-size-fits-all approach toward individualized, patient-specific clinical decisions to help healthcare professionals deliver the right therapy to the right patient, every time.

Image of clinician caring for a hospital patient

Proper Fluid Management Is Critical, But Fluid Responsiveness Is Dynamic

Over 80% of hospitalized patients receive IV fluids.1 Despite the importance of fluid therapy, studies show administering too little or too much fluid can lead to serious complications and contribute to rising healthcare costs.2,3

Every patient has unique and constantly changing fluid management needs, and fluids should be dosed according to patient response. Assessing whether fluid may help or harm a patient is a critical step in optimizing treatment for the individual patient – only about 50% of hemodynamically unstable patients will respond to IV fluid by increasing cardiac output and perfusion.4 The Starling system can provide the information a clinician needs to determine whether a patient will benefit from additional fluid.

Image of the Starling system being operated by a gloved hand.

More Informed Clinical Decision-Making

The Starling system offers an accurate, reliable and non-invasive method to measure blood flow at the patient’s core and deliver meaningful insights to guide clinical decision-making. Using unique Bioreactance technology, it provides a full hemodynamic profile within seconds, with 94% sensitivity and 100% specificity for predicting fluid responsiveness in critical care situations.4

100% non-invasive

Supports individualized fluid therapy without requiring an invasive arterial or central line, potentially reducing the risk of hospital-acquired infections and other complications5

Easy-to-perform dynamic assessments

The Starling monitor guides clinicians through a step-by-step protocol for executing a passive leg raise or bolus test

Real-time, continuous information

Provides real-time, continuous information on cardiac index, cardiac output, stroke volume index, stroke volume and total peripheral resistance

Rx Only.

For safe and proper use of the product mentioned herein, please refer to the appropriate Operator's Manual or Instructions for Use.